MapLight Therapeutics, Inc.
MPLT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| % Growth | – | – | – |
| Cost of Goods Sold | $1 | $1 | $1 |
| Gross Profit | -$1 | -$1 | -$1 |
| % Margin | – | – | – |
| R&D Expenses | $68 | $49 | $27 |
| G&A Expenses | $0 | $0 | $0 |
| SG&A Expenses | $14 | $8 | $4 |
| Sales & Mktg Exp. | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 |
| Operating Expenses | $82 | $57 | $31 |
| Operating Income | -$83 | -$57 | -$31 |
| % Margin | – | – | – |
| Other Income/Exp. Net | $5 | $2 | $1 |
| Pre-Tax Income | -$78 | -$56 | -$30 |
| Tax Expense | $0 | $0 | $0 |
| Net Income | -$78 | -$56 | -$30 |
| % Margin | – | – | – |
| EPS | -1.87 | -1.34 | -0.72 |
| % Growth | -39.6% | -86.1% | – |
| EPS Diluted | -1.87 | -1.34 | -0.72 |
| Weighted Avg Shares Out | 41 | 41 | 41 |
| Weighted Avg Shares Out Dil | 41 | 41 | 41 |
| Supplemental Information | – | – | – |
| Interest Income | $5 | $1 | $0 |
| Interest Expense | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 |
| EBITDA | -$77 | -$55 | -$29 |
| % Margin | – | – | – |